The solution incorporates computer vision to support the clinical assessment of a condition affecting nearly 500 people in Cantabria. The Marqués de Valdecilla Research Institute (IDIVAL), the University of Cantabria (UC) and Viacore IT have developed an innovative application that facilitates the treatment of diabetic foot for healthcare professionals without specialized podiatry training. Thanks to […]
A team of researchers from the Valdecilla Research Institute (IDIVAL) and the University of Cantabria has developed a targeted nanomedicine capable of selectively delivering chemotherapy to tumors, avoiding toxic effects on healthy tissues. The study, which reports promising preclinical results, has been published in the prestigious journal Small. The Nanomedicine Group at IDIVAL and the […]
The Marqués de Valdecilla University Hospital (HUMV) and the IDIVAL Health Research Institute are advancing in the multicenter clinical trial CASSANDRA, which evaluates in humans the experimental drug IDP-121, a direct cMyc inhibitor — a key protein involved in the development of most cancers. This phase I/II study is aimed at patients with Multiple Myeloma, […]
The research, conducted by professionals from the Marqués de Valdecilla University Hospital and researchers from the IDIVAL Health Research Institute, evaluates the usefulness of the GAP index as a prognostic marker in patients with interstitial lung diseases referred for transplantation. Researchers from the Marqués de Valdecilla Research Institute (IDIVAL), in collaboration with the Pulmonology Department […]
A team from the Immunopathology Group at IDIVAL, the University of Cantabria, and the Cantabrian Health Service has discovered a relationship between bone metabolism and vulnerability to SARS-CoV-2. The study, led by Drs. Emilio Pariente and José Luis Hernández, was recently published in the scientific journal Current Medical Research and Opinion and sheds light on […]
This Monday, the Marqués de Valdecilla Research Institute (IDIVAL) welcomed Glòria Oliver Rodríguez, Deputy Director General of the Pasqual Maragall Foundation, and Joan Vives i Tomàs, Administrative Director of the Centre for Genomic Regulation (CRG). During their visit to IDIVAL’s headquarters in Santander, they held a meeting with Galo Peralta Fernández, Managing Director, Marcos López […]
The project Transcriptomics and artificial intelligence for predicting adverse cardiac remodeling in patients undergoing surgery for aortic valve stenosis, funded by the INNVAL 2021 call from the Marqués de Valdecilla Research Institute (IDIVAL), has focused on studying omics data from left ventricle biopsies of patients with severe aortic stenosis who underwent valve replacement surgery at […]
Chronic lymphocytic leukaemia (CLL) is one of the most common haematological diseases in older adults, with a higher incidence in men than in women. Despite advances in treatment, it remains an incurable disease, and patients eventually develop resistance to available therapies. In this context, a team of researchers led by Carlos Pipaón, from the Haematological […]
The Valdecilla Health Research Institute (IDIVAL) is participating as an associate entity in the European project JADE Health (Joint Action on Dementia and Health System Sustainability), a joint action funded by the European Commission under the EU4Health program. This initiative, which brings together institutions from various European countries, aims to improve prevention, early diagnosis, and […]
On February 14, 2025, a workshop was held at IDIVAL’s LiNNUX Lab, in collaboration with FISABIO and with the participation of LASINDE. Under the title “How can we improve healthcare mobility in Cantabria?”, the event brought together healthcare professionals, innovation experts and health service users, who contributed valuable ideas and perspectives on the topic. The […]
